title: First multifocal bullous fixed drug eruption due to etodolac.
authors: Kirikkale University School of Medicine, Division of Immunologic and Allergic Diseases, Kirikkale, Turkey. Electronic address: ilkay.koca@gmail.com.
authors: I
authors: I
authors: Koca Kalkan
authors: Kirikkale University School of Medicine, Division of Immunologic and Allergic Diseases, Kirikkale, Turkey.
authors: A F
authors: AF
authors: Kalpaklioglu
authors: Kirikkale University School of Medicine, Department of Pathology, Kirikkale, Turkey.
authors: P
authors: P
authors: Atasoy
authors: Kirikkale University School of Medicine, Department of Dermatology, Kirikkale, Turkey.
authors: A A
authors: AA
authors: Karabulut
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D001323:Autoantibodies / Q000097:blood; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis* / Q000276:immunology; D004804:Eosinophils / Q000276:immunology*; D004817:Epidermis / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D017308:Etodolac / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D013961:Thyroid Gland / Q000276:immunology; D028761:Withholding Treatment
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001323:Autoantibodies; D052246:Cyclooxygenase 2 Inhibitors; D017308:Etodolac